SCHEMBL18564310

SCHEMBL18564310

CC1(C)c2ccccc2-c2ccc3c(c21)c1ccccc1n3-c1ccc(-c2nc(-c3cccc(-n4c5ccccc5c5c6c(ccc54)-c4ccccc4C6(C)C)c3)cc(-c3cccc(-n4c5ccccc5c5c6c(ccc54)-c4ccccc4C6(C)C)c3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.31
PDK2 Q15119 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
FLT3 P36888 1/20 0.30
BMX P51813 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18564313 0.99 MEN1 (0.32) RXFP1PDK2KDM4EMEN1ALDH1A1
SCHEMBL18564390 0.97 KDM4E (0.32) RXFP1PDK2KDM4EMEN1ALDH1A1
SCHEMBL15625636 0.94 MEN1 (0.34) RXFP1KDM4EMEN1ALDH1A1LMNA
SCHEMBL18564388 0.94 RXFP1 (0.32) RXFP1KDM4E
SCHEMBL18564372 0.94 RXFP1 (0.32) RXFP1KDM4E
SCHEMBL24078768 0.93 MEN1 (0.34) RXFP1PDK2KDM4EMEN1ALDH1A1
SCHEMBL25966162 0.92 MEN1 (0.32) RXFP1PDK2KDM4EMEN1ALDH1A1
SCHEMBL25966454 0.92 KDM4E (0.35) RXFP1KDM4EALDH1A1
SCHEMBL25966553 0.91 KDM4E (0.34) RXFP1KDM4E
SCHEMBL22865686 0.90 KDM4E (0.31) KDM4EMEN1ALDH1A1LMNAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 RXFP1 4854/4885PDK2 4209/4885KDM4E 225/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 RXFP1 4854/4885PDK2 4209/4885KDM4E 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.